The RNA-binding protein HuR stabilizes cytosolic phospholipase A 2α mRNA under Interleukin-1β treatment in non-small cell lung cancer A549 cells

Wan Lin Liao, Wei Chiao Wang, Wen Chang Chang, Joseph T. Tseng

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The activation of cytosolic phospholipase A 2α (cPLA 2α) plays an important role in initiating the inflammatory response. The regulation of cPLA 2α mRNA turnover has been proposed to control cPLA 2α gene expression under cytokine and growth factor stimulation. However, the detailed mechanism is still unknown. In this report, we have demonstrated that the cPLA 2α mRNA stability was increased under IL-1β treatment in A549 cells. By using EMSAs, HuR was identified as binding with the cPLA 2α mRNA 3′-UTR, and the binding region was located at nucleotides 2716-2807, a fragment containing AUUUA flanked by U-rich sequences. IL-1β treatment enhanced the association of cPLA 2α mRNA with cytosolic HuR. The reduction of HuR expression by RNA interference technology inhibited IL-1β-induced cPLA 2α mRNA and protein expression. Furthermore, blocking the p38 MAPK signaling pathway with SB203580 abolished the effect of IL-1β-induced cPLA 2α gene expression. Phosphorylation at residue Thr-118 of HuR is crucial in regulating the interaction between HuR and its target mRNAs. Mutation of HuR Thr-118 reduced the association between HuR and cPLA 2α mRNA under IL-1β treatment. This inhibitory effect was also observed in binding with COX-2 mRNA. This result indicated that p38 MAPK-mediated Thr-118 phosphorylation may play a key role in regulating the interaction of HuR with its target mRNAs in inflammation.

Original languageEnglish
Pages (from-to)35499-35508
Number of pages10
JournalJournal of Biological Chemistry
Volume286
Issue number41
DOIs
Publication statusPublished - Oct 14 2011

Fingerprint

RNA-Binding Proteins
Phospholipases A
Interleukin-1
Non-Small Cell Lung Carcinoma
Cells
Messenger RNA
Phosphorylation
p38 Mitogen-Activated Protein Kinases
Gene expression
Association reactions
Gene Expression
A549 Cells
RNA Stability
3' Untranslated Regions
RNA Interference
Intercellular Signaling Peptides and Proteins
Nucleotides
Chemical activation
RNA
Cytokines

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

The RNA-binding protein HuR stabilizes cytosolic phospholipase A 2α mRNA under Interleukin-1β treatment in non-small cell lung cancer A549 cells. / Liao, Wan Lin; Wang, Wei Chiao; Chang, Wen Chang; Tseng, Joseph T.

In: Journal of Biological Chemistry, Vol. 286, No. 41, 14.10.2011, p. 35499-35508.

Research output: Contribution to journalArticle

@article{3afe109e3a5748cfa79272155548224c,
title = "The RNA-binding protein HuR stabilizes cytosolic phospholipase A 2α mRNA under Interleukin-1β treatment in non-small cell lung cancer A549 cells",
abstract = "The activation of cytosolic phospholipase A 2α (cPLA 2α) plays an important role in initiating the inflammatory response. The regulation of cPLA 2α mRNA turnover has been proposed to control cPLA 2α gene expression under cytokine and growth factor stimulation. However, the detailed mechanism is still unknown. In this report, we have demonstrated that the cPLA 2α mRNA stability was increased under IL-1β treatment in A549 cells. By using EMSAs, HuR was identified as binding with the cPLA 2α mRNA 3′-UTR, and the binding region was located at nucleotides 2716-2807, a fragment containing AUUUA flanked by U-rich sequences. IL-1β treatment enhanced the association of cPLA 2α mRNA with cytosolic HuR. The reduction of HuR expression by RNA interference technology inhibited IL-1β-induced cPLA 2α mRNA and protein expression. Furthermore, blocking the p38 MAPK signaling pathway with SB203580 abolished the effect of IL-1β-induced cPLA 2α gene expression. Phosphorylation at residue Thr-118 of HuR is crucial in regulating the interaction between HuR and its target mRNAs. Mutation of HuR Thr-118 reduced the association between HuR and cPLA 2α mRNA under IL-1β treatment. This inhibitory effect was also observed in binding with COX-2 mRNA. This result indicated that p38 MAPK-mediated Thr-118 phosphorylation may play a key role in regulating the interaction of HuR with its target mRNAs in inflammation.",
author = "Liao, {Wan Lin} and Wang, {Wei Chiao} and Chang, {Wen Chang} and Tseng, {Joseph T.}",
year = "2011",
month = "10",
day = "14",
doi = "10.1074/jbc.M111.263582",
language = "English",
volume = "286",
pages = "35499--35508",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "41",

}

TY - JOUR

T1 - The RNA-binding protein HuR stabilizes cytosolic phospholipase A 2α mRNA under Interleukin-1β treatment in non-small cell lung cancer A549 cells

AU - Liao, Wan Lin

AU - Wang, Wei Chiao

AU - Chang, Wen Chang

AU - Tseng, Joseph T.

PY - 2011/10/14

Y1 - 2011/10/14

N2 - The activation of cytosolic phospholipase A 2α (cPLA 2α) plays an important role in initiating the inflammatory response. The regulation of cPLA 2α mRNA turnover has been proposed to control cPLA 2α gene expression under cytokine and growth factor stimulation. However, the detailed mechanism is still unknown. In this report, we have demonstrated that the cPLA 2α mRNA stability was increased under IL-1β treatment in A549 cells. By using EMSAs, HuR was identified as binding with the cPLA 2α mRNA 3′-UTR, and the binding region was located at nucleotides 2716-2807, a fragment containing AUUUA flanked by U-rich sequences. IL-1β treatment enhanced the association of cPLA 2α mRNA with cytosolic HuR. The reduction of HuR expression by RNA interference technology inhibited IL-1β-induced cPLA 2α mRNA and protein expression. Furthermore, blocking the p38 MAPK signaling pathway with SB203580 abolished the effect of IL-1β-induced cPLA 2α gene expression. Phosphorylation at residue Thr-118 of HuR is crucial in regulating the interaction between HuR and its target mRNAs. Mutation of HuR Thr-118 reduced the association between HuR and cPLA 2α mRNA under IL-1β treatment. This inhibitory effect was also observed in binding with COX-2 mRNA. This result indicated that p38 MAPK-mediated Thr-118 phosphorylation may play a key role in regulating the interaction of HuR with its target mRNAs in inflammation.

AB - The activation of cytosolic phospholipase A 2α (cPLA 2α) plays an important role in initiating the inflammatory response. The regulation of cPLA 2α mRNA turnover has been proposed to control cPLA 2α gene expression under cytokine and growth factor stimulation. However, the detailed mechanism is still unknown. In this report, we have demonstrated that the cPLA 2α mRNA stability was increased under IL-1β treatment in A549 cells. By using EMSAs, HuR was identified as binding with the cPLA 2α mRNA 3′-UTR, and the binding region was located at nucleotides 2716-2807, a fragment containing AUUUA flanked by U-rich sequences. IL-1β treatment enhanced the association of cPLA 2α mRNA with cytosolic HuR. The reduction of HuR expression by RNA interference technology inhibited IL-1β-induced cPLA 2α mRNA and protein expression. Furthermore, blocking the p38 MAPK signaling pathway with SB203580 abolished the effect of IL-1β-induced cPLA 2α gene expression. Phosphorylation at residue Thr-118 of HuR is crucial in regulating the interaction between HuR and its target mRNAs. Mutation of HuR Thr-118 reduced the association between HuR and cPLA 2α mRNA under IL-1β treatment. This inhibitory effect was also observed in binding with COX-2 mRNA. This result indicated that p38 MAPK-mediated Thr-118 phosphorylation may play a key role in regulating the interaction of HuR with its target mRNAs in inflammation.

UR - http://www.scopus.com/inward/record.url?scp=80053903690&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053903690&partnerID=8YFLogxK

U2 - 10.1074/jbc.M111.263582

DO - 10.1074/jbc.M111.263582

M3 - Article

C2 - 21862584

AN - SCOPUS:80053903690

VL - 286

SP - 35499

EP - 35508

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 41

ER -